InvestLog
GLUE Monte Rosa Therapeutics, Inc. logo

GLUE Monte Rosa Therapeutics, Inc.

Healthcare
$18.88+0.00%OpenMarket Cap: $1.23B

As of 2026-05-26

Insider Statistics (Q2 2026)

Acquisitions

3

Dispositions

5

Buy/Sell Ratio

0.60

Net Shares

-5,512

Shares Acquired

33,800

Shares Disposed

39,312

Total Bought ($)

$0.00

Total Sold ($)

$4.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Fri May 22Manning Anthony M.directorSell10,000$18.010
Fri May 22Manning Anthony M.directorSell10,000$4.1612,100
Tue May 05Warmuth Markusdirector, officer: President & CEOSell5,467$18.92600,004
Wed Apr 15Warmuth Markusdirector, officer: President & CEOSell8,000$17.64605,471
Fri Apr 10Nickson Philipofficer: Chief Business & Legal OfficerSell5,845$17.6955,000
Tue Apr 07Bowen Matthewofficer: Principal Accounting OfficerSell19,500$16.9319,500
Tue Apr 07Bowen Matthewofficer: Principal Accounting OfficerSell4,300$0.0025,904
Tue Apr 07Bowen Matthewofficer: Principal Accounting OfficerSell10,800$7.110
Tue Apr 07Bowen Matthewofficer: Principal Accounting OfficerSell9,950$13.410
Tue Apr 07Bowen Matthewofficer: Principal Accounting OfficerSell5,500$23.990
Tue Apr 07Bowen Matthewofficer: Principal Accounting OfficerSell3,698$5.710
Tue Apr 07Bowen Matthewofficer: Principal Accounting OfficerSell3,551$7.780
Tue Apr 07Bowen Matthewofficer: Principal Accounting OfficerSell1,501$6.300
Tue Apr 07Bowen Matthewofficer: Principal Accounting OfficerSell625$7.500
Tue Apr 07Bowen Matthewofficer: Principal Accounting OfficerSell0$0.0021,604